Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Adderall
  2. Adderall XR
  3. Mydayis

Canadian Brand Name

  1. ACT Amphetamine XR - 10MG Tablet
  2. ACT Amphetamine XR - 15MG Tablet
  3. ACT Amphetamine XR - 20MG Tablet
  4. ACT Amphetamine XR - 25MG Tablet
  5. ACT Amphetamine XR - 30MG Tablet
  6. ACT Amphetamine XR - 5MG Tablet
  7. APO-Amphetamine XR - 10MG Tablet
  8. APO-Amphetamine XR - 15MG Tablet
  9. APO-Amphetamine XR - 20MG Tablet
  10. APO-Amphetamine XR - 25MG Tablet
  11. APO-Amphetamine XR - 30MG Tablet
  12. APO-Amphetamine XR - 5MG Tablet

Descriptions


Amphetamine and dextroamphetamine combination is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (uncontrollable desire for sleep or sudden attacks of deep sleep). These two medicines belong to the group of medicines called central nervous system (CNS) stimulants.

Amphetamine and dextroamphetamine combination works in the treatment of ADHD to increase attention and decrease restlessness in patients who are overactive, cannot concentrate, or are easily distracted. It is used as part of a total treatment program that also includes social, educational, and psychological therapy.

This medicine is available only with a doctor's prescription. Prescriptions cannot be refilled. A new prescription must be obtained from your doctor each time you need this medicine.

This product is available in the following dosage forms:

  • Capsule, Extended Release
  • Tablet

From Mayo Clinic to your inbox

Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Portions of this document last updated: Feb. 01, 2023

Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.